Lawrence Otto Klein

Director; Director, Chief Executive Officer · 4 filings · Latest: Jun 15, 2026

Jade Biosciences, Inc.

Oruka Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ORKA	Lawrence Otto Klein	Director, Chief Executive Officer	Jun 15, 2026	Sale	$69.69	1,729	$120.5K	925,580	Jun 15 10:52 PM
ORKA	Lawrence Otto Klein	Director, Chief Executive Officer	Mar 16, 2026	Sale	$41.30	1,729	$71.4K	927,309	Mar 17 8:10 PM